These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8476233)

  • 41. [Inhaled antibiotic therapy in cystic fibrosis].
    Girón Moreno RM; Salcedo Posadas A; Mar Gómez-Punter R
    Arch Bronconeumol; 2011 Jun; 47 Suppl 6():14-8. PubMed ID: 21703474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The management of cystic fibrosis. Observations on gentamycin when used with other antibiotics in pulmonary infections associated with cystic fibrosis.
    Shwachman H; Khaw KT; Kowalski SM
    Clin Pediatr (Phila); 1975 Dec; 14(12):1115-8. PubMed ID: 1192683
    [No Abstract]   [Full Text] [Related]  

  • 43. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection].
    Mordasini C; Aebischer CC; Schoch OD
    Schweiz Med Wochenschr; 1997 May; 127(21):905-10. PubMed ID: 9289818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled tobramycin: not just for cystic fibrosis anymore?
    Lobue PA
    Chest; 2005 Apr; 127(4):1098-101. PubMed ID: 15821180
    [No Abstract]   [Full Text] [Related]  

  • 45. [Pseudomonas aeruginosa infection in cystic fibrosis. The importance of early antibiotic therapy].
    Dutau G; Brémont F
    Rev Mal Respir; 1990; 7(3):183-5. PubMed ID: 2114027
    [No Abstract]   [Full Text] [Related]  

  • 46. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
    Hata JS; Fick RB
    Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.
    Paporisz U; Posselt HG; Wönne R; Ristow W; Röser D; Knothe H; Bender SW
    Monogr Paediatr; 1979; 10():31-3. PubMed ID: 460275
    [No Abstract]   [Full Text] [Related]  

  • 48. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
    Lahiri T
    Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lung infection.
    Strandvik B; Hjelte L; Lindblad A; Ljungberg B; Malmborg AS; Nilsson-Ehle I
    Scand J Infect Dis Suppl; 1989; 60():84-8. PubMed ID: 2756354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of inhaled antibiotics in cystic fibrosis patients.
    Wunderlich P; Paul KD; Wehner J
    Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A ten year review of colomycin.
    Littlewood JM; Koch C; Lambert PA; Høiby N; Elborn JS; Conway SP; Dinwiddie R; Duncan-Skingle F
    Respir Med; 2000 Jul; 94(7):632-40. PubMed ID: 10926333
    [No Abstract]   [Full Text] [Related]  

  • 52. The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.
    Kasetty G; Bhongir RKV; Papareddy P; Herwald H; Egesten A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection.
    Beaulac C; Clément-Major S; Hawari J; Lagacé J
    Antimicrob Agents Chemother; 1996 Mar; 40(3):665-9. PubMed ID: 8851590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should pulmonary exacerbations in cystic fibrosis be treated with antibiotics?
    Bosso JA
    Drug Intell Clin Pharm; 1984 Oct; 18(10):825-6. PubMed ID: 6489166
    [No Abstract]   [Full Text] [Related]  

  • 55. Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia.
    Geddes DM
    Chest; 1988 Aug; 94(2 Suppl):140S-145S. PubMed ID: 3293940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of ciprofloxacin in children with cystic fibrosis.
    Orenstein DM; Pattishall EN; Noyes BE; Kurland G; Hartigan ER; Yu VL
    Clin Pediatr (Phila); 1993 Aug; 32(8):504-6. PubMed ID: 8403750
    [No Abstract]   [Full Text] [Related]  

  • 57. Fluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosis.
    Hurley M; Smyth A
    Ther Adv Respir Dis; 2012 Dec; 6(6):363-73. PubMed ID: 22968160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antibiotic therapy in cystic fibrosis. II Antibiotic strategy].
    Sermet-Gaudelus I; Ferroni A; Gaillard JL; Silly C; Chretiennot C; Lenoir G; Berche P
    Arch Pediatr; 2000 Jun; 7(6):645-56. PubMed ID: 10911533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat lung model.
    Grimwood K; To M; Rabin HR; Woods DE
    J Antimicrob Chemother; 1989 Dec; 24(6):937-45. PubMed ID: 2516085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic review of nebulized antibiotics in cystic fibrosis: evolution of protocol.
    Mukhopadhyay S; Singh M; Ogston S; Ryan G; Smyth R
    J R Soc Med; 1998; 91 Suppl 34(Suppl 34):25-9. PubMed ID: 9709385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.